These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

636 related articles for article (PubMed ID: 32838726)

  • 1. On the Cytotoxicity of Chiral Ruthenium Complexes Containing Sulfur Amino Acids against Breast Tumor Cells (MDA-231 and MCF-7).
    Leite CM; de Araujo-Neto JH; Corrêa RS; Colina-Vegas L; Martínez-Otero D; Martins PR; Silva CG; Batista AA
    Anticancer Agents Med Chem; 2021; 21(9):1172-1182. PubMed ID: 32838726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving Cytotoxicity against Breast Cancer Cells by Using Mixed-Ligand Ruthenium(II) Complexes of 2,2'-Bipyridine, Amino Acid, and Nitric Oxide Derivatives as Potential Anticancer Agents.
    Gaspari APS; da Silva RS; Carneiro ZA; de Carvalho MR; Carvalho I; Pernomian L; Ferreira LP; Ramos LCB; de Souza GA; Formiga ALB
    Anticancer Agents Med Chem; 2021; 21(12):1602-1611. PubMed ID: 33081686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxicity and anti-tumor effects of new ruthenium complexes on triple negative breast cancer cells.
    Popolin CP; Reis JPB; Becceneri AB; Graminha AE; Almeida MAP; Corrêa RS; Colina-Vegas LA; Ellena J; Batista AA; Cominetti MR
    PLoS One; 2017; 12(9):e0183275. PubMed ID: 28898246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic activity and structural features of Ru(II)/phosphine/amino acid complexes.
    Dos Santos ER; Graminha AE; Schultz MS; Correia I; Selistre-de-Araújo HS; Corrêa RS; Ellena J; Lacerda EPS; Pessoa JC; Batista AA
    J Inorg Biochem; 2018 May; 182():48-60. PubMed ID: 29433005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the potential of ruthenium(II)-phosphine-mercapto complexes as new anticancer agents.
    Palmeira-Mello MV; Costa AR; de Oliveira LP; Blacque O; Gasser G; Batista AA
    Dalton Trans; 2024 Jul; 53(26):10947-10960. PubMed ID: 38895770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ru(II)-Naphthoquinone complexes with high selectivity for triple-negative breast cancer.
    Oliveira KM; Peterson EJ; Carroccia MC; Cominetti MR; Deflon VM; Farrell NP; Batista AA; Correa RS
    Dalton Trans; 2020 Nov; 49(45):16193-16203. PubMed ID: 32329497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo antitumor activity of a novel carbonyl ruthenium compound, the ct-[RuCl(CO)(dppb)(bipy)]PF-6[dppb=1,4-bis(diphenylphosphine)butane and bipy=2,2'-bipyridine].
    Carnizello AP; Barbosa MI; Martins M; Ferreira NH; Oliveira PF; Magalhães GM; Batista AA; Tavares DC
    J Inorg Biochem; 2016 Nov; 164():42-48. PubMed ID: 27613330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic Ruthenium(II) Complexes Containing a Dangling Pyridine: Selectivity for Diseased Cells Mediated by pH-Dependent DNA Binding.
    Sangeetha S; Murali M
    Inorg Chem; 2022 Feb; 61(6):2864-2882. PubMed ID: 35099196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxicity of Ru(II) piano-stool complexes with chloroquine and chelating ligands against breast and lung tumor cells: Interactions with DNA and BSA.
    Colina-Vegas L; Villarreal W; Navarro M; de Oliveira CR; Graminha AE; Maia PIDS; Deflon VM; Ferreira AG; Cominetti MR; Batista AA
    J Inorg Biochem; 2015 Dec; 153():150-161. PubMed ID: 26277415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cis-[RuCl(BzCN)(N-N)(P-P)]PF6 complexes: Synthesis and in vitro antitumor activity: (BzCN=benzonitrile; N-N=2,2'-bipyridine; 1,10-phenanthroline; P-P=1,4-bis(diphenylphosphino) butane, 1,2-bis(diphenylphosphino)ethane, or 1,1'-(diphenylphosphino)ferrocene).
    Pereira Fde C; Lima BA; de Lima AP; Pires WC; Monteiro T; Magalhães LF; Costa W; Graminha AE; Batista AA; Ellena J; Siveira-Lacerda Ede P
    J Inorg Biochem; 2015 Aug; 149():91-101. PubMed ID: 25873134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-mutagenic Ru(ii) complexes: cytotoxicity, topoisomerase IB inhibition, DNA and HSA binding.
    da Silva MM; de Camargo MS; Correa RS; Castelli S; De Grandis RA; Takarada JE; Varanda EA; Castellano EE; Deflon VM; Cominetti MR; Desideri A; Batista AA
    Dalton Trans; 2019 Oct; 48(39):14885-14897. PubMed ID: 31555783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological assessment of a ruthenium(II) cyclopentadienyl complex in breast cancer cells and on the development of zebrafish embryos.
    Golbaghi G; Pitard I; Lucas M; Haghdoost MM; de Los Santos YL; Doucet N; Patten SA; Sanderson JT; Castonguay A
    Eur J Med Chem; 2020 Feb; 188():112030. PubMed ID: 31945643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the biological potential of ruthenium(II) complexes with cinnamic acid.
    Graminha AE; Honorato J; Dulcey LL; Godoy LR; Barbosa MF; Cominetti MR; Menezes AC; Batista AA
    J Inorg Biochem; 2020 May; 206():111021. PubMed ID: 32163810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic activity of Ru(II)/DPEPhos/N,S-mercapto complexes (DPEPhos = bis-[(2-diphenylphosphino)phenyl]ether).
    Grawe GF; Oliveira KM; Leite CM; de Oliveira TD; Costa AR; Moraes CAF; Honorato J; Cominetti MR; Castellano EE; Correa RS; Machado SP; Batista AA
    J Inorg Biochem; 2023 Jul; 244():112204. PubMed ID: 37004320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel ruthenium(ii) gallic acid complex disrupts the actin cytoskeleton and inhibits migration, invasion and adhesion of triple negative breast tumor cells.
    Graminha AE; Honorato J; Correa RS; Cominetti MR; Menezes ACS; Batista AA
    Dalton Trans; 2021 Jan; 50(1):323-335. PubMed ID: 33305766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxicity evaluation and DNA interaction of Ru
    de Almeida PSVB; de Arruda HJ; Sousa GLS; Ribeiro FV; de Azevedo-França JA; Ferreira LA; Guedes GP; Silva H; Kummerle AE; Neves AP
    Dalton Trans; 2021 Oct; 50(41):14908-14919. PubMed ID: 34609400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ruthenium(II) Phosphine/Mercapto Complexes: Their in Vitro Cytotoxicity Evaluation and Actions as Inhibitors of Topoisomerase and Proteasome Acting as Possible Triggers of Cell Death Induction.
    Ribeiro GH; Guedes APM; de Oliveira TD; de Correia CRSTB; Colina-Vegas L; Lima MA; Nóbrega JA; Cominetti MR; Rocha FV; Ferreira AG; Castellano EE; Teixeira FR; Batista AA
    Inorg Chem; 2020 Oct; 59(20):15004-15018. PubMed ID: 32997499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pro-apoptotic activity of ruthenium 1-methylimidazole complex on non-small cell lung cancer.
    Dias JSM; Silva HVR; Ferreira-Silva GÁ; Ionta M; Corrêa CC; Almeida F; Colina-Vegas L; Barbosa MIF; Doriguetto AC
    J Inorg Biochem; 2018 Oct; 187():1-13. PubMed ID: 30015231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New ruthenium complexes containing salicylic acid and derivatives induce triple-negative tumor cell death via the intrinsic apoptotic pathway.
    Graminha AE; Popolin C; Honorato de Araujo-Neto J; Correa RS; de Oliveira KM; Godoy LR; Vegas LC; Ellena J; Batista AA; Cominetti MR
    Eur J Med Chem; 2022 Dec; 243():114772. PubMed ID: 36191406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of in vitro absorption in Caco-2 monolayers of anticancer Ru(II)-based complexes acting as dual human topoisomerase and PARP inhibitors.
    de Camargo MS; De Grandis RA; da Silva MM; da Silva PB; Santoni MM; Eismann CE; Menegário AA; Cominetti MR; Zanelli CF; Pavan FR; Batista AA
    Biometals; 2019 Feb; 32(1):89-100. PubMed ID: 30506342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.